- SNN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
-
6-K Filing
Smith & Nephew (SNN) 6-KDirector/pdmr Shareholding
Filed: 12 Nov 24, 6:39am
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument | Smith & Nephew plc ordinary shares of USD 0.20 each |
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2024 interim dividend payment on 8 November 2024. |
Date of Transaction | 2024 - 11 - 08 |
Place of Transaction | London Stock Exchange (XLON) |
Name (Position) | Director / PDMR | Price | Volume | Aggregated information |
Helen Barraclough (Group General Counsel and Company Secretary) | PDMR | 9.234 | 421.23522 | N/A Single Transaction |
Paul Connolly (President, Global Operations) | PDMR | 9.234 | 194.91162 | N/A Single Transaction |
Phil Cowdy Chief Corporate Development & Corporate Affairs Officer | PDMR | 9.234 | 1.9035 | N/A Single Transaction |
Mizanu Kebede (Chief Quality & Regulatory Affairs Officer) | PDMR | 9.234 | 111.64316 | N/A Single Transaction |
Deepak Nath (Chief Executive Officer) | Director | 9.234 | 1924.20518 | N/A Single Transaction |
Scott Schaffner (President, Sports Medicine) | PDMR | 9.234 | 794.95718 | N/A Single Transaction |
Smith & Nephew plc | ||
(Registrant) | ||
Date: November 11, 2024 | By: | /s/ Helen Barraclough |
Helen Barraclough | ||
Company Secretary |